IRIS
DE LUCA, Arianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.370
EU - Europa 903
AS - Asia 153
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 3
Totale 2.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.335
UA - Ucraina 297
DE - Germania 154
IT - Italia 150
AT - Austria 136
SE - Svezia 92
SN - Senegal 67
CN - Cina 47
CA - Canada 35
IN - India 31
TR - Turchia 29
FI - Finlandia 24
FR - Francia 22
HK - Hong Kong 19
KR - Corea 18
BE - Belgio 10
NL - Olanda 8
AU - Australia 5
EU - Europa 5
LT - Lituania 5
SG - Singapore 3
GB - Regno Unito 2
AZ - Azerbaigian 1
BR - Brasile 1
CL - Cile 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 2.506
Salva come PNG Salva come JPEG
Città #
Chandler 323
Jacksonville 159
San Mateo 137
Vienna 92
Rende 89
New York 81
Dakar 67
Dearborn 67
Ashburn 50
Lawrence 48
Roxbury 47
Ottawa 31
Des Moines 26
Izmir 26
Shanghai 25
Helsinki 24
Brooklyn 23
Cambridge 23
Seoul 18
Wilmington 18
Inglewood 17
Beijing 16
Bremen 16
Hong Kong 16
Hanover 15
Pune 13
Seattle 13
Ogden 12
Brussels 10
Palermo 10
Ann Arbor 9
Florence 8
Cosenza 7
Groningen 6
Redwood City 6
Grafing 5
Fremont 4
Norwalk 4
Rome 4
San Francisco 4
Bhubaneswar 3
Caserta 3
Central 3
Los Angeles 3
Melbourne 3
Ningbo 3
Toronto 3
Bangalore 2
Berlin 2
Canberra 2
Washington 2
Amsterdam 1
Borås 1
Centro 1
Chicago 1
Colombo 1
Crotone 1
Haikou 1
Hanoi 1
Harbin 1
Hefei 1
Lattarico 1
Lincoln 1
London 1
Monmouth Junction 1
Nagold 1
Oklahoma City 1
Paola 1
Princeton 1
Redmond 1
Riga 1
Salerno 1
Secaucus 1
São Paulo 1
Tallinn 1
Tokyo 1
Vientiane 1
Totale 1.624
Salva come PNG Salva come JPEG
Nome #
Cyclooxygenase (Cox)-2 regulating transcriptional and post-transcriptional activation of aromatase is involved in Leydig cell tumor proliferation 92
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 91
Cholesterol as an endogenous ERRα agonist: A new perspective to cancer treatment 82
Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC) 80
Activation of G-protein-coupled estrogen receptor (GPER) inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new target for ACC treatment. 80
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment 78
Cross-talk between estrogen and IGF-II signalling in adrenocortical tumor cell proliferation. 74
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 73
17 β-estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocytes-derived cell line. 72
Activation of G-Protein-Coupled Estrogen Receptor (GPER) inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new target for ACC treatment. 72
Cholesterol as new target for ACC therapy. 70
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 66
Antitumoral activities of curcumin and recent advances to improve its oral bioavailability 66
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 64
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to inhibit growth and invasion of adrenocortical carcinoma (ACC) Università della Calabria 63
XCT790 an inverse agonist of estrogen related receptor alpha (ERRalpha) inhibits cellular metabolism, motility and invasion of adrenocortical cancer cell line H295R. 59
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 59
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 58
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo. 56
Estrogen Related Receptor α (ERRα) As Potential Target for a New Adrenocortical Carcinoma (ACC) Therapy 54
The metabolic regulator estrogen-related receptor alpha as a therapeutic target in Adrenocortical Carcinoma (ACC). 54
Role of GPER-Mediated Signaling in Testicular Functions and Tumorigenesis 54
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 52
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 50
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 48
Mitotane activates GPER-dependent pathways leading to apoptosis of human adrenocortical carcinoma H295R cell line. 47
Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells 44
A Resveratrol Phenylacetamide Derivative Perturbs the Cytoskeleton Dynamics Interfering with the Migration Potential in Breast Cancer 43
The Novel Estrogen Receptor GPR30 Mediates the Proliferative Effects Induced by 17beta-Estradiol on GC-1 Mouse Spermatogonial Cell Line 43
SIRT1 is involved in adrenocortical cancer growth and motility 43
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 42
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway 42
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 40
GPR30 mediates estradiol-proliferative effects on GC-1 mouse spermatogonial cell line through ERK/Fos activation 40
Involvment of Cyclooxygenase-2 (COX-2) in regulating estrogen-dependent Leydig cell tumor proliferation 40
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 40
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to fight adrenocortical carcinoma (ACC) progression and as useful tool to determine ACC stem cell-like proprieties. 40
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line 39
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 38
The Estrogen Related Receptor α (ERRα) inverse agonist XCT-790 reduces adrenocortical cancer (ACC) H295R cells growth in vitro and in vivo. 38
Estrogen Receptors‐Mediated Apoptosis in Hormone‐Dependent Cancers 38
Oleuropein and hydroxytyrosol activates GPER-dependent pathways inducing apoptosis in ER-negative breast cancer cells SKBR3. 37
Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth. 35
Inhibition cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cell 34
A phenylacetamide resveratrol derivative exerts inhibitory effects on breast cancer cell growth. 34
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 33
THE CENTRAL ROLE OF ESTROGEN RECEPTOR α IN IGF-II DEPENDENT ADRENOCORTICAL CARCINOMA (ACC) CELL PROLIFERATION SUGGESTS THE USE OF SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMs) IN THE TREATMENT OF ACC. 32
Interactions between ERα, GPR30, EGFR and IGF1R and their role in controlling adrenocortical tumor cell proliferation 27
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression 22
Totale 2.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 2 26 0
2019/2020328 26 27 0 50 14 66 18 28 36 8 44 11
2020/2021386 62 21 42 43 11 34 3 65 35 38 2 30
2021/2022643 1 102 4 44 81 8 7 144 11 10 78 153
2022/2023773 92 133 53 87 107 62 2 78 76 21 22 40
2023/2024377 41 20 21 35 27 138 16 15 41 23 0 0
Totale 2.578